In severely demented Alzheimer's disease patients (CDR stage 3) expected to have a high degree of cell loss, the density of sigma-2 receptors remains unchanged compared to age-matched normal individuals, while the density of the unrelated sigma-1 receptor is decreased by 54%, as has been previously reported [43]. This evidence concerns the gene TMEM97 and early-onset autosomal dominant Alzheimer disease.